Association of rhinovirus infections with asthma

Clinical Microbiology Reviews

Volumn 12, Issue 1, 1999, Pages 9-18

  Gern, James E ^a,b   Busse, William W ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; ASCORBIC ACID; BROMPHENIRAMINE; CAPSID PROTEIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLEMASTINE; CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PREDNISOLONE; PROTEINASE INHIBITOR; VASOCONSTRICTOR AGENT; ZINC;

ALLERGIC ASTHMA; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMON COLD; CYSTIC FIBROSIS; DROWSINESS; DRUG MECHANISM; ENDOTHELIUM CELL; EPITHELIUM CELL; GRANULOCYTE; HUMAN; HUMAN RHINOVIRUS; IMMUNE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT; MACROPHAGE; NERVOUS TISSUE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; REVIEW; SEASONAL VARIATION; T LYMPHOCYTE; UPPER RESPIRATORY TRACT; VIROLOGY; VIRUS INFECTION; WHEEZING;

EID: 0032937896     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.12.1.9     Document Type: Review

References (140)

1. al-Nakib, W., and D. A. Tyrrell. 1992. Drugs against rhinoviruses. J. Antimicrob. Chemother. 30:115-117.
2. Alwan, W. H., W. J. Kozlowska, and P. J. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89.
3. + T-cells. Clin. Exp. Immunol. 88:527-536.
4. Angelini, B., B. S. Van Deusen, W. J. Doyle, J. Seroky, S. Cohen, and D. P. Skoner. 1997. Lower airway responses to rhinovirus-Hanks in healthy subjects with and without allergy. J. Allergy Clin. Immunol. 99:618-619.
5. Anticevich, S. Z., J. M. Hughes, J. L. Black, and C. L. Armour. 1995. Induction of human airway hyperresponsiveness by tumour necrosis factor-alpha. Eur. J. Pharmacol. 284:221-225.
6. Arnold, R., B. Humbert, H. Werchau, H. Gallati, and W. Konig. 1994. Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology 82:126-133.
7. Arruda, E., T. R. Boyle, B. Winther, D. C. Pevear, J. M. Gwaltney, and F. G. Hayden. 1995. Localization of human rhinovirus replication in the upper respiratory tract by in situ hybridization. J. Infect. Dis. 171:1329-1333.
8. Arruda, E., T. E. Mifflia, J. M. Jr. Gwaltney, B. Winther, and F. G. Hayden. 1991. Localization of rhinovirus replication in vitro with in situ hybridization. J. Med. Virol. 54:634-638.
9. Arruda, E., A. Pitkaranta, T. J. J. Witek, C. A. Doyle, and F. G. Hayden. 1997. Frequency and natural history of rhinovirus infections in adults during autumn. J. Clin. Microbiol. 35:2864-2868.
10. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signalling pathways by the chemokine RANTES. Science 269:1727-1730.
11. 4 production in wheezy infants. Clin. Exp. Allergy 24:121-126.
12. Bardin, P. G., S. L. Johnston, and P. K. Pattemore. 1992. Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms. Clin. Exp. Allergy 22:809-822.
13. Bardin, P. G., S. L. Johnston, G. Sanderson, B. S. Robinson, M. A. Pickett, D. J. Fraenkel, and S. T. Holgate. 1994. Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am. J. Respir. Cell Mol. Biol. 10:207-213.
14. Bardin, P. G., G. Sanderson, B. S. Robinson, S. T. Holgate, and D. A. J. Tyrrell. 1996. Experimental rhinovirus infection in volunteers. Eur. Respir. J. 9:2250-2255.
15. Bates, P. J., P. G. Bardin, D. J. Fraenkel, G. Sanderson, S. T. Holgate, and S. L. Johnston. 1998. Localisation of rhinovirus in the bronchial epithelium of experimentally-infected human volunteers. Am. J. Respir. Crit. Care Med. 157:A25. (Abstract.)
16. Baumgarth, N., L. Brown, D. Jackson, and A. Kelso. 1994. Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J. Virol. 68:7575-7581.
17. Becker, S., J. Quay, and J. Soukup. 1991. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147:4307-4312.
18. Brunette, M. G., L. Lands, and L. P. Thibodeau. 1988. Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infections. Pediatrics 81:624-629.
19. Busse, W. W., and J. E. Gern. 1997. Viruses in asthma. J. Allergy Clin. Immunol. 100:147-150.
20. Busse, W. W., R. F. Vrtis, R. Steiner, and E. C. Dick. 1991. In vitro incubation with influenza virus primes human polymorphonuclear leukocyte generation of superoxide. Am. J. Respir. Cell Mol. Biol. 4:347-354.
21. Calhoun, W. J., E. C. Dick, L. B. Schwartz, and W. W. Busse. 1994. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J. Clin. Invest. 94:2200-2208.
22. Calhoun, W. J., C. A. Swenson, E. C. Dick, L. B. Schwartz, R. F. Lemanske, Jr., and W. W. Busse. 1991. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 144:1267-1273.
23. Cannon, M. J., P. J. M. Openshaw, and B. A. Askonas. 1988. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168:1163-1168.
24. Cheung, D., E. C. Dick, M. C. Timmers, E. P. A. De Klerk, W. J. M. Spaan, and P. J. Sterk. 1995. Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am. J. Respir. Crit. Care Med. 152:1490-1496.
25. de Gouw, H. W. F. M., K. Grünberg, R. Schot, A. C. M. Kroes, E. C. Dick, and P. J. Sterk. 1998. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur. Respir. J. 11:126-132.
26. Denny, F. W., and W. A. Clyde, Jr. 1986. Acute lower respiratory tract infections in nonhospitalized children. J. Pediatr. 108:635-646.
27. Dick, E. C., C. R. Blumer, and A. S. Evans. 1967. Epidemiology of infections with rhinoviruses type 43 and 5 in a group of University of Wisconsin student families. Am. J. Epidemiol. 86:386-400.
28. Dick, E. C. and S. L. Inhorn. 1992. Rhinoviruses, p. 1507-1532. In R. D. Feigin and J. D. Cherry (ed.), Textbook of pediatric infectious diseases, 3rd ed. The W. B. Saunders Co., Philadelphia, Pa.
29. Dicosmo, B. F., G. P. Geba, D. Picarella, J. A. Elias, J. A. Rankin, B. R. Stripp, J. A. Whitsett, and R. A. Flavell. 1994. Airway epithelial cell expression of interleukin-6 in transgenic mice - uncoupling of airway inflammation and bronchial hyperreactivity. J. Clin. Invest. 94:2028-2035.
30. + T-cell memory to viruses. Curr. Opin. Immunol. 6:545-552.
31. Duff, A. L., E. S. Pomeranz, L. E. Gelber, H. W. Price, H. Farris, F. G. Hayden, T. A. E. Platts-Mills, and P. W. Heymann. 1993. Risk factors for acute wheezing in infants in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 92:535-540.
32. Einarsson, O., G. P. Geba, Z. Zhu, M. Landry, and J. A. Elias. 1996. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97:915-924.
33. Empey, D. W., L. A. Laitinen, L. Jacobs, W. M. Gold, and J. A. Nadel. 1976. Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection. Am. Rev. Respir. Dis. 113:131-139.
34. Everard, M. L., A. Swarbrick, M. Wrightham, J. Mcintyre, C. Dunkley, P. D. James, H. F. Sewell, and A. D. Milner. 1994. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch. Dis. Child. 71:428-432.
35. Fahy, J. V., K. W. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95:843-852.
36. Farr, B. M., J. M. J. Gwaltney, J. O. Hendley, F. G. Hayden, R. M. Naclerio, T. McBride, W. J. Doyle, J. V. Sorrentino, D. K. Riker, and D. Proud. 1990. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J. Infect. Dis. 162:1173-1177.
37. Ferguson, E. A., and R. Eccles. 1997. Changes in nasal nitric oxide concentration associated with symptoms of common cold and treatment with a topical nasal decongestant. Acta Oto-Laryngol. 117:614-617.
38. Fiedler, M. A., K. Wernke-Dollries, and J. M. Stark. 1995. Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am. J. Physiol. 269:L865-L872.
39. Folkerts, G., W. W. Busse, F. P. Nijkamp, R. Sorkness, and J. E. Gern. 1998. State of the art: virus-induced airway hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med. 157:1708-1720.
40. Folkerts, G., H. J. Linde van der, and F. P. Nijkamp. 1995. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J. Clin. Invest. 95:26-30.
41. Folkerts, G., and F. P. Nijkamp. 1995. Virus-induced airway hyperresponsiveness: Role of inflammatory cells and mediators. Am. J. Resp. Crit. Care Med. 151:1666-1674.
42. Folkerts, G., A. Verheyen, M. Janssen, and F. P. Nijkamp. 1992. Virus-induced airway hyperresponsiveness in the guinea pig can be transferred by bronchoalveolar cells. J. Allergy Clin. Immunol. 90:364-72.
43. Fraenkel, D. J., P. G. Bardin, G. Sanderson, F. Lampe, S. L. Johnston, and S. T. Holgate. 1995. Lower airway inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir. Crit. Care Med. 151:879-886.
44. Frick, W. E., D. German, and J. Mills. 1979. Development of allergy in children. I. Association with virus infection. J. Allergy Clin. Immunol. 63:228-241.
45. Gama, R. E., P. R. Horsnell, P. J. Hughes, C. North, C. B. Bruce, W. al-Nakib, and G. Stanway. 1989. Amplification of rhinovirus specific nucleic acids from clinical samples using the polymerase chain reaction. J. Med. Virol. 28:73-77.
46. Garafalo, R., F. Mei, R. Espejo, H. Ye, H. Haeherde, S. Baron, P. Ogra, and V. E. Reyes. 1996. Respiratory syncylial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through induction of IFN-β and IL-1α. J. Immunol. 157:2506-2513.
47. Garofalo, R., J. L. L. Kimpen, R. C. Welliver, and P. L. Ogra. 1992. Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr. 120:28-32.
48. Gern, J. E., and W. W. Busse. 1995 The effects of rhinovirus infections on allergic airway responses. Am. J. Respir. Crit. Care Med. 152:S40-S45.
49. Gern, J. E., and W. W. Busse. 1996. Role of T cells in virus-induced asthma, p. 39-66. In S. B. Liggett and D. A Meyers (ed.). The genetics of asthma. Marcel Dekker, Inc., New York, N.Y.
50. Gern, J. E., W. J. Calhoun, C. Swenson, G. Shen, and W. W. Busse. 1997. Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am. J. Respir. Crit. Care Med. 155:1872-1876.
51. Gern, J. E., E. C. Dick, E. A. B. Kelly, R. Vrtis, and B. Klein. 1997. Rhinovirus-specific T cells recognize both shared and serotype-restricted viral epitopes. J. Infect. Dis. 175:1108-1114.
52. Gern, J. E., E. C. Dick, W. M. Lee, S. Murray, K. Meyer, Z. T. Handzel, and W. W. Busse. 1996. Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J. Immunol. 156:621-627.
53. Gern, J. E., D. M. Galagan, N. N. Jarjour, E. C. Dick, and W. W. Busse. 1997. Detection of rhinovirus RNA in lower airway cells during experimentally-induced infection. Am. J. Respir. Crit. Care Med. 155:1159-1161.
54. Gern, J. E., K. A. Sukow, C. Swenson, E. C. Dick, and W. W. Busse. 1997. Correlation of nasal cytokines and symptoms during experimental rhinovirus infection. J. Allergy Clin. Immunol. 99:S130. (Abstract.)
55. Gern, J. E., R. Vrtis, E. A. B. Kelly, E. C. Dick, and W. W. Busse. 1996. Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J. Immunol. 157:1605-1612.
56. Gosset, P., A. Tsicopoulos, B. Wallaert, C. Vannimenus, M. Joseph, A. B. Tonnel, and A. Capron. 1991. Increased secretion of tumor necrosis factor a and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J. Allergy Clin. Immunol. 88:561-571.
57. Grünberg, K., H. H. Smits, M. C. Timmers, E. P. A. de Klerk, R. J. Dolhain, E. C. Dick, P. S. Hiemstra, and P. J. Sterk. 1997. Experimental rhinovirus 16 infection. Effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am. J. Respir. Crit. Care Med. 156:609-616.
58. Grünberg, K., M. C. Timmers, H. H. Smits, E. P. A. De Klerk, E. C. Dick, W. J. M. Spaan, P. S. Hiemstra, and P. J. Sterk. 1997. Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin-8 in nasal lavage in asthmatic subjects in vivo. Clin. Exp. Allergy 27:36-45.
59. Gustatson, L. M., D. Proud, J. O. Hendley, F. G. Hayden, and J. M. Gwaltney. 1996. Oral prednisone therapy in experimental rhinovirus infections. J. Allergy Clin. Immunol. 97:1009-1014.
60. Gwaltney, J. M., Jr., and H. M. Druce. 1997. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin. Infect. Dis. 25:1188-1194.
61. Gwaltney, J. M., Jr., J. Park, R. A. Paul, D. A. Edelman, R. R. O'Connor, and R. B. Turner. 1996. Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. Clin. Infect. Dis. 22: 656-662.
62. Gwaltney, J. M., Jr. 1998. Where's the bias? Ann. Intern. Med. 128:75. (Letter.)
63. Halperin, S. A., P. A. Eggleston, P. Beasley, P. Suratt, J. O. Hendley, D. H. Gröschel, and J. M. Gwaltney, Jr. 1985. Exacerbations of asthma in adults during experimental rhinovirus infection. Am. Rev. Respir. Dis. 132:976-980.
64. Halperin, S. A., P. A. Eggleston, J. O. Hendley, P. M. Suratt, D. H. Gröschel, and J. M. Jr. Gwaltney. 1983. Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am. Rev. Respir. Dis. 128: 806-810.
65. Halperin, S. A., P. M. Suratt, J. M. Gwaltney, Jr., D. H. Gröschel, J. O. Hendley, and P. A. Eggleston. 1982 Bacterial cultures of the lower respiratory tract in normal volunteers with and without experimental rhinovirus infection using a plugged double catheter system. Am. Rev. Respir. Dis. 125:678-680.
66. Handzel, Z. T., W. W. Busse, J. B. Sedgwick, R. Vrtis, W. M. Lee, E. A. B. Kelly, and J. E. Gern. 1998. Eosinophils bind rhinovirus and activate virus-specific T cells. J. Immunol. 160:1279-1284.
67. 2-interferon. N. Engl. J. Med. 314:71-75.
68. Hayden, F. G., L. Diamond, P. B. Wood, D. C. Korts, and M. T. Wecker. 1996. Effectiveness and safety of intranasal ipratropium bromide in common colds - a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 125:89-89.
69. Hayden, F. G., G. J. Hipskind, D. H. Woerner, G. F. Eisen, M. Janssens, P. A. J. Janssen, and K. Andries. 1995. Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob. Agents Chemother. 39:290-294.
70. Henderson, F. W., W. A. Clyde, Jr., A. M. Collier, F. W. Denny, R. J. Senior, C. I. Sheaffer, W. G. Conley, and R. M. Christian. 1979. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J. Pediatr. 95:183-190.
71. Heymann, P. W., G. P. Rakes, A. D. Hogan, J. M. Ingram, G. E. Hoover, and T. A. Platts-Mills. 1995. Assessment of eosinophils, viruses and IgE antibody in wheezing infants and children. Int. Arch. Allergy Immunol. 107: 380-382.
72. Higgins, P. G., G. I. Barrow, and D. A. Tyrrell. 1990. A study of the efficacy of the bradykinin antagonist, NPC 567, in rhinovirus infections in human volunteers. Antiviral Res. 14:339-344.
73. Horn, M. E. C., E. Brain, and I. Gregg. 1974. Respiratory viral infections in childhood. A survey in general practice. J. Hyg. 157:157-168.
74. Horn, M. E. C., S. E. Reed, and P. Taylor. 1979. Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum. Arch. Dis. Child. 54:587-592.
75. Hsia, J., A. L. Goldstein, G. L. Simon, M. Sztein, and F. G. Hayden. 1990. Peripheral blood mononuclear cell interleukin-2 and interferon-gamma production, cytotoxicity, and antigen-stimulated blastogenesis during experimental rhinovirus infection. J. Infect. Dis. 162:591-597.
76. Huguenel, E. D., D. Cohn, D. P. Dockum, J. M. Greve, M. A. Fournel, L. Hammond, R. Irwin, J. Mahoney, A. McClelland, E. Muchmore, A. C. Ohlin, and P. Scuderi. 1997. Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am. J. Respir. Crit. Care Med. 155:1206-1210.
77. Igarashi, Y., D. P. Skoner, W. J. Doyle, M. V. White, P. Fireman, and M. A. Kaliner. 1993. Analysis of nasal secretions during experimental rhinovirus upper respiratory infections. J. Allergy Clin. Immunol. 92:722-731.
78. Jackson, J. L., C. Peterson, and E. Lesho. 1997. A meta-analysis of zinc salts lozenges and the common cold. Arch. Intern. Med. 157:2373-2376.
79. Johnston, S. L., A. Papi, P. J. Bates, J. G. Mastronarde, M. M. Monick, and G. W. Hunninghake. 1998. Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J. Immunol. 160:6172-6181.
80. Johnston, S. L., P. K. Pattemore, G. Sanderson, S. Smith, M. J. Campbell, L. K. Josephs, A. Cunningham, B. S. Robinson, S. H. Myint, M. E. Ward, D. A. J. Tyrrell, and S. T. Holgate. 1996. The relationship between upper respiratory infections and hospital admissions for asthma: a time trend analysis. Am. J. Respir. Crit. Care Med. 154:654-660.
81. Johnston, S. L., P. K. Pattemore, G. Sanderson, S. Smith, F. Lampe, L. Josephs, P. Symington, S. O'Toole, S. H. Myint, D. A. Tyrrell, and S. T. Holgate. 1995. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br. Med. J. 310:1225-1229.
82. Johnston, S. L., P. Xie, and W. Johnson. 1996. Comparison of standard virology and PCR in diagnosis of rhinovirus and respiratory syncytial virus infections in nasal aspirates from children hospitalized with wheezing illness and bronchiolitis. Am. J. Respir. Crit. Care Med. 153:A503. (Abstract.)
83. Kameyoshi, Y., A. Dorschner, A. I. Mallet, E. Christophers, and J. M. Schroder. 1992. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J. Exp. Med. 176:587-592.
84. Kellner, G., T. Popow-Kraupp, M. Kundi, C. Binder, and C. Kunz. 1989. Clinical manifestations of respiratory tract infections due to respiratory syncytial virus and rhinoviruses in hospitalized children. Acta Paediatr. Scand. 78:390-394.
85. Kharitonov, S. A., D. Yates, and P. J. Barnes. 1995. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur. Respir. J. 8:295-297.
86. Laitinen, L. A., R. B. Elkin, D. W. Empey, L. Jacobs, J. Mills, and J. A. Nadel. 1991. Bronchial hyperresponsiveness in normal subjects during attenuated influenza virus infection. Am. Rev. Respir. Dis. 143:358-361.
87. Laitinen, L. A., and T. Kava. 1980. Bronchial reactivity following uncomplicated influenza A infection in healthy subjects and in asthmatic patients. Eur. J. Respir. Dis. 10:51-58.
88. Las Heras, J. and V. L. Swanson. 1983. Sudden death of an infant with rhinovirus infection complicating bronchial asthma: case report. Pediatr. Pathol. 1:319-323.
89. Lemanske, R. F., Jr., E. C. Dick, C. A. Swenson, R. F. Vrtis, and W. W. Busse. 1989. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J. Clin. Invest. 83:1-10.
90. Levandowski, R. A., D. W. Ou, and G. G. Jackson. 1986. Acute-phase decrease of T lymphocyte subsets in rhinovirus infection. J. Infect. Dis. 153:743-748.
91. Levandowski, R. A., C. W. Weaver, and G. G. Jackson. 1988. Nasal secretion leukocyte populations determined by flow cytometry during acute rhinovirus infection. J. Med. Virol. 25:423-432.
92. Lopez, A. F., D. J. Williamson, J. R. Gamble, C. G. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wong, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 78:1220-1228.
93. Mills, J. S. 1996. Viral protease inhibitors - what next after HIV? Antiviral Chem. Chemother. 7:281-293.
94. Minor, T. E., E. C. Dick, J. W. Baker, J. J. Ouellette, M. Cohen, and C. E. Reed. 1976. Rhinovirus and influenza type A infections as precipitants of asthma. Am. Rev. Respir. Dis. 113:149-153.
95. Minor, T. E., E. C. Dick, A. N. DeMeo, J. J. Ouellette, M. Cohen, and C. E. Reed. 1974. Viruses as precipitants of asthmatic attacks in children. JAMA 227:292-298.
96. Monto, A. S., and J. J. Cavallaro. 1971. The Tecumseh study of respiratory illness. II. Patterns of occurrence of infection with respiratory pathogens. Am. J. Epidemiol. 94:280-289.
97. Mossad, S. B., M. L. Macknin, S. V. Medendorp, and P. Mason. 1996. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann. Intern. Med. 125:81-88.
98. Naclerio, R. M., D. Proud, L. M. Lichtenstein, A. Kagey-Sobotka, J. O. Hendley, J. Sorrentino, and J. M. Gwaltney. 1988. Kinins are generated during experimental rhinovirus colds. J. Infect. Dis. 157:133-142.
99. Nagata, M., Sedgwick, J. B., and Busse, W. W. 1997. Synergistic activation of eosinophil superoxide anion generation by VCAM-1 and GM-CSF. Involvement of tyrosine kinase and protein kinase C. Int. Arch. Allergy Immunol. 114:578-80.
100. Nakazawa, H., K. Sekizawa, M. Morikawa, K. Yamauchi, M. Satoh, K. Maeyama, T. Watanabe, and H. Sasaki. 1994. Viral respiratory infection causes airway hyperresponsiveness and decreases histamine N-methyltransferase activity in guinea pigs. Am. J. Respir. Crit. Care Med. 149:1180-1185.
101. Nicholson, K. G., J. Kent, V. Hammersley, and E. Cancio. 1996. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study. Br. Med. J. 313:1119-1123.
102. Nicholson, K. G., J. Kent, and D. C. Ireland. 1993. Respiratory viruses and exacerbations of asthma in adults. Br. Med. J. 307:982-986.
103. Noah, T. L., F. W. Henderson, I. A. Wortman, R. B. Devlin, J. Handy, H. S. Koren, and S. Becker. 1995. Nasal cytokine production in viral acute upper respiratory infection of childhood. J. Infect. Dis. 171:584-592.
104. Pattemore, P. K., S. L. Johnston, and P. G. Bardin. 1992. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin. Exp. Allergy 22: 325-336.
105. Proud, D., J. M. Jr. Gwaltney, J. O. Hendley, C. A. Dinarello, S. Gillis, and R. P. Schleimer. 1994. Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J. Infect. Dis. 169:1007-1013.
106. Proud, D., R. M. Naclerio, J. M. Gwaltney, and J. O. Hendley. 1990. Kinins are generated in nasal secretions during natural rhinovirus colds. J. Infect. Dis. 161:120-123.
107. Rager, K. J., J. O. Langland, B. L. Jacobs, D. Proud, D. G. Marsh, and F. Imani. 1998. Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J. Virol. 72:1171-1176.
108. Raz, M., R. A. Robbins, C. L. Kelling, L. C. Stine, G. D. Leikauf, S. I. Rennard, and J. R. Spurzem. 1993. Viral infection of bovine bronchial epithelial cells induces increased neutrophil chemotactic activity and neutrophil adhesion. Exp. Lung Res. 85:753-760.
109. Rimmelzwaan, G. F., and A. D. M. E. Osterhaus. 1995. Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza? Vaccine 13:703-705.
110. Rosenwirth, B., Z. L. Kis, and H. J. Eggers. 1995. In vivo efficacy of SDZ 35-682, a new picornavirus capsid-binding agent. Antiviral Res. 26:55-64.
111. Rothlein, R., M. Czajkowski, M. M. O'Neill, S. D. Marlin, E. Mainolfi, and V. J. Merluzzi. 1988. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. J. Immunol. 141:1665-1669.
112. Sanders, S. P., E. S. Siekierski, J. D. Porter, S. M. Richards, and D. Proud. 1998. Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J. Virol. 72:934-942.
113. Sarawar, S. R., and P. C. Doherty. 1994. Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J. Virol. 68:3112-3119.
114. Schuster, A., J. V. Fahy, I. Ueki, and J. A. Nadel. 1995. Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors. Eur. Respir. J. 8:10-14.
115. Sedgwick, J. B., S. F. Quan, W. J. Calhoun, and W. W. Busse. 1995. Effect of interleukin-5 and granulocyte-macrophage colony stimulating factor on in vitro eosinophil function: Comparison with airway eosinophils. J. Allergy Clin. Immunol. 96:375-385.
116. Skoner, D. P., W. J. Doyle, J. Seroky, and P. Fireman. 1996. Lower airway re sponses to influenza A virus in healthy allergic and nonallergic subjects. Am. J. Respir. Crit. Care Med. 154:661-664.
117. Skoner, D. P., W. J. Doyle, J. Seroky, M. A. Vandeusen, and P. Fireman. 1996. Lower airway responses to rhinovirus 39 in healthy allergic and nonallergic subjects. Eur. Respir. J. 9:1402-1406.
118. Skoner, D. P., W. J. Doyle, E. P. Tanner, J. Kiss, and P. Fireman. 1995. Effect of rhinovirus 39 (RV-39) infection on immune and inflammatory parameters in allergic and non-allergic subjects. Clin. Exp. Allergy 25:561-567.
119. Stellato, C., L. A. Beck, G. A. Gorgone, D. Proud, T. J. Schall, S. J. Ono, L. M. Lichtenstein, and R. P. Schleimer. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line. J. Immunol. 155:410-418.
120. Sterk, P. J. 1993. Virus-induced airway hyperresponsiveness in man. Eur. Respir. J. 6:894-902.
121. Subauste, M. C., D. B. Jacoby, S. M. Richards, and D. Proud. 1995. Infection of a human respiratory epithelial cell line with rhinovirus - Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 96:549-557.
122. Summers, Q. A., P. G. Higgins, I. G. Barrow, D. A. Tyrrell, and S. T. Holgate. 1992. Bronchial reactivity to histamine and bradykinin is unchanged after rhinovirtis infection in normal subjects. Eur. Respir. J. 5:313-317.
123. Tang, W., G. P. Geba, T. Zheng, P. Ray, R. J. Homer, C. Kuhn, R. A. Flavell, and J. A. Elias. 1996. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J. Clin. Invest. 98:2845-2853.
124. Terajima, M., M. Yamaya, K. Sekizawa, S. Okinaga, T. Suzuki, N. Yamada, K. Nakayama, T. Ohrui, T. Oshima, Y. Numazaki, and H. Sasaki. 1997. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1beta. Am. J. Physiol. 273:L749-L759.
125. Teran, L. M., S. L. Johnston, J. M. Schroder, M. K. Church, and S. T. Holgate. 1997. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am. J. Respir. Crit. Care Med. 155:1362-1366.
126. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947-1950.
127. Trigg, C. J., K. G. Nicholson, J. H. Wang, D. C. Ireland, S. Jordan, J. M. Duddle, S. Hamilton, and R. J. Daview. 1996. Bronchial inflammation and the common cold: a comparison of atopic and non-atopic individuals. Clin. Exp. Allergy 26:665-676.
128. Turner, R. B. 1990. The role of neutrophils in the pathogenesis of rhinovirus infections. Pediatr. Infect. Dis. J. 9:832-835.
129. Turner, R. B., F. J. Dutko, N. H. Goldstein, G. Lockwood, and F. G. Hayden. 1993. Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob. Agents Chemother. 37:297-300.
130. Turner, R. B., K. W. Weingand, C. H. Yeh, and D. W. Leedy. 1998. Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin. Infect. Dis. 26:840-846.
131. Van Oosterhout, A. J. M., I. van Ark, G. Folkerts, H. J. van der Linde, Savelkoul, HF, A. K. Verheyen, and F. P. Nijkamp. 1995. Antibody to interleukin-5 inhibits virus-induced airway hyperresponsiveness to histamine in guinea pigs. Am. J. Respir. Crit. Care Med. 151:177-183.
132. Wimalasundera, S. S., D. R. Katz, and B. M. Chain. 1997. Characterization of the T cell response to human rhinovirus in children: implications for understanding the immunopathology of the common cold. J. Infect. Dis. 176:755-759.
133. Winther, B., B. Farr, R. B. Thoner, J. O. Hendley, N. Mygrind, and J. M. Gwaltney. 1984. Histopathologic examination and enumeration of polymorphonuclear leukocytes in the nasal mucosa during experimental rhinovirus colds. Acta Otolaryngol (Stockh) 413(Suppl.):19-24.
134. Winther, B., J. M. Jr. Gwaltney, M. Mygind, R. B. Turner, and J. O. Hendley. 1986. Sites of rhinovirus recovery after point inoculation of the upper airway. JAMA 256:1763-1767.
135. Winther, B., J. M. Greve, J. M. Gwaltney Jr., D. J. Innes, J. R. Eastham, A. Mcclelland, and J. O. Hendley. 1997. Surface expression of intercellular adhesion molecule 1 on epithelial cells in the human adenoid. J. Infect. Dis. 176:523-525.
136. 2 interferon and viral exacerbations of chronic respiratory disease. Thorax 46:706-711.
137. Zhang, L., A. E. Redington, and S. T. Holgate. 1994. RANTES: A novel mediator of allergic inflammation? Clin. Exp. Allergy 24:899-904.
138. Zhou, S., J. M. Stark, and G. D. Leikauf. 1995. Leukotriene B4 formation: human neutrophil-airway epithelial cell interactions. J. Appl. Physiol. 78: 1396-1403.
139. Zhu, Z., W. Tang, J. M. J. Gwaltney, Y. Wu, and J. A. Elias. 1997. Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am. J. Physiol. 273:L814-L824
140. Zhu, Z., W. Tang, Y. Wu, O. Einarsson, M. L. Landry, J. M. Gwaltney, Jr., and J. A. Elias. 1996. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J. Clin. Invest. 97:421-430.